MaxCyte signs platform license agreement with Adicet Bio
MaxCyte’s Flow Electroporation technology and ExPERT platform to support the development of Adicet’s gamma delta T cell therapy gene edited programs
MaxCyte’s Flow Electroporation technology and ExPERT platform to support the development of Adicet’s gamma delta T cell therapy gene edited programs
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific
With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship
With its unique combination of low-cost and high accuracy, ppmSeq marks a real breakthrough in sequencing technology
Learn how Inotiv’s proteomics services are helping researchers gain deeper insights into drug target systems, to better select disease models, and quantify pathology data
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists
Compact, high-sensitivity solution for accurate macromolecule analysis
Combining Syncell’s Microscoop technology and Thermo Fisher’s Orbitrap Astral mass spectrometer series
Project is led by the Max-Planck Institute of Molecular Plant Physiology and also includes academics from University of Essex and UC Berkeley
This discovery can offer chocolate producers a powerful tool to craft consistently high-quality, flavor-rich chocolate
Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC
Enabling accurate and accessible ethyl alcohol testing across moderate complexity laboratories
As part of our aim to improve our service to scientists and laboratory professionals, we invite you to complete the SelectScience 2025 survey
Initiative to expand testing access to underserved U.S. communities
As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap
'Scripting Possibilities' to power the future of biotechnology
Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, and neurofilament in Alzheimer’s disease diagnostics
Secure your ticket to visit the biggest lab industry trade show in the UK
The launch marks the highlight of a 10-year journey
A focused clinical approach to second-generation anti-seizure medications and laboratory diagnostics
Cleanroom microbiology expert, Cherwell, to become AnalytiChem UK Ltd from 1st September 2025
Understaffing in the lab threatens the collaboration doctors depend on